About You

Normally, men and nonpregnant women have just traces of prolactin in their blood. It will show whether there’s a mass near your pituitary gland and how big it is. If your value falls outside the normal range, this doesn’t automatically mean you have a problem. What’s considered normal may be different depending on which lab your doctor uses.
Patients who are on long-acting SQ pellets require two separate assessments of testosterone to determine the dose and frequency required. As with short-acting IM testosterone injections, the general recommendation is mid-cycle testing, after equilibration, and halfway between the first two 10-week injections. Given the mechanisms of action of anastrozole, clomiphene citrate, and hCG, patients using these medications should wait a longer period before follow-up blood work is performed. For patients on daily medication, the Panel recommends that patients use medication the day of follow-up blood work. In addition to issues relating to the reliability of compounded products themselves, appropriate clinical studies on pharmacokinetics are lacking. With respect to testosterone specifically, Grober et al. conducted an analysis of compounded testosterone creams/gels from 10 pharmacies in Toronto, Canada.410 Each pharmacy was given two prescriptions for 50 mg of testosterone, separated by 1 month to assess both intra-pharmacy and inter-pharmacy consistency. In 2001, the FDA performed an analysis of internet-purchased, compounded products following reports of contamination, poor compounding processes, and product toxicity.406, 407 Among 29 product samples analyzed, which included testosterone among multiple medications, 31% demonstrated sub-potency ranging from 59-89% below target dose.
Thus, pituitary dysfunction can develop after radiation therapy for sellar, parasellar, and extrasellar neoplasms (e.g., craniopharyngiomas, meningiomas, germinomas, chordomas, hemangio-pericytomas, pituicytomas, gliomas), head and neck tumors, and following total body irradiation for systemic malignancies. BMD increased in patients treated with testosterone therapy leading the authors to conclude that younger testosterone deficient men may benefit from having routine DEXA scans performed, particularly those with concomitant low E2 and low BMI.89 A systematic review found that varicocele ligation results in significant improvement in testosterone levels in some men, with a mean improvement of approximately 100 ng/dL. Point estimates that measure the difference in testosterone levels between men with and without ED may appear statistically significant, but these estimates are not always clinically meaningful. A challenge in making the diagnosis of testosterone deficiency is that many of the symptoms reported by patients are non-specific and might be related to conditions other than low testosterone. Total testosterone  absence of signs and/or symptoms increases the likelihood of making a false diagnosis and reduces the potential benefit of testosterone therapy.
Some men and clinicians have observed that when starting testosterone replacement therapy (TRT), prolactin levels might rise. In one review, researchers noted that hyperprolactinemia from a pituitary adenoma is a rare cause of erectile dysfunction, but whenever a man has erectile dysfunction plus low testosterone, a prolactin level should be measured to rule this out. Because prolactin has such a suppressive effect on male hormone balance, it is standard medical practice to measure prolactin levels whenever a man is found to have low testosterone (especially with low or normal gonadotropins). Men with elevated prolactin (a condition called hyperprolactinemia) often develop hypogonadism (testosterone deficiency) with symptoms such as decreased libido, erectile dysfunction, infertility, fatigue, and even bone density loss.
When people are pregnant or have just given birth, their prolactin levels increase so they can make breast milk. Dopamine agonists, commonly prescribed for the pharmacological management of hyperprolactinemia, appear to influence sexual functioning, particularly in men. In our cohort, baseline prolactin levels were mildly elevated, with a mean of 38.22 ± 30.68 ng/mL. In other words, \"normal\" circulating testosterone in these patients did not guarantee normal androgen effect – a concept supported by their symptomatic improvement when prolactin was lowered and testosterone rose slightly. In line with previous studies, 6,12,14–16 our results indicated that individuals with idiopathic hyperprolactinemia frequently experience low libido, erectile dysfunction, weakness, and gynecomastia. Elevated levels of prolactin, as predominately observed in conditions such as prolactinoma, can disrupt these processes, resulting in symptoms such as ED and infertility. (B) Although not statistically significant, cabergoline demonstrated a more pronounced reduction in prolactin levels compared to bromocriptine.
Hyperprolactinemia means you have high levels of prolactin in your blood. People assigned male at birth have lower levels of prolactin. Furthermore, cabergoline treatment has been found to improve sexual drive and function, as well as positively impact the perception of the refractory period.
Conversely, the minimum scores were 0 for intercourse satisfaction and orgasmic function, 1 for erectile function, and 2 for sexual desire and overall satisfaction. The maximum scores are 15 for intercourse satisfaction and 10 for orgasmic function, sexual desire, and overall satisfaction. In our laboratory, the reference range for PRL levels in men is 4.04–15.2 ng/mL, with levels exceeding 200 ng/mL were determined following appropriate serum dilutions. Normalization of PRL levels determined the efficacy of PRL secretion control. Informed consent was obtained from all patients prior to treatment, and all patients agreed to the use of their clinical data. Their medical records were reviewed for clinical characteristics, signs and symptoms, International Index of Erectile Function (IIEF)-15 score, laboratory tests, MRI scans, treatment approach, duration of treatment and response to treatment. Therefore, although HPRL is a rather rare condition, it can lead to male sexual dysfunction and should not be overlooked due to its potential reversibility .
All patients were treated with bromocriptine, except for five patients who were intolerant to bromocriptine switched to cabergoline. Testosterone is converted by 5α-reductase into the most potent androgen dihydrotestosterone (DHT), which binds to androgen receptor (AR) to exert its promotive effects on penile erection and libido . Pituitary height reduction may serve as an important diagnostic marker and indicator of treatment effectiveness. Eighteen patients received bromocriptine, whereas five patients received cabergoline. Primary complaints at diagnosis included low libido, gynecomastia, impotence, and erectile dysfunction.
A hematocrit above ~52-54% is concerning because it may thicken the blood and increase the risk of clotting problems (like stroke or thromboembolism). This is why in the U.S., testosterone prescriptions often come with the plan for regular PSA tests. Also, if severe urinary symptoms develop (difficulty urinating, etc.), the dose might need reduction or a BPH medication added. Most studies have not shown TRT to significantly increase prostate cancer incidence, but vigilance is maintained. This is to screen for any occult prostate cancer, since adding testosterone could theoretically stimulate an existing cancer. Overall, DHT is part of the testosterone ecosystem, and its effects are mostly \"side effects\" we monitor (skin and prostate changes). An alternative strategy is lowering the testosterone dose if possible.

Profile Info